Sensyne Health has completed a $76m initial public offering and will begin trading on Aim tomorrow, offering an exit to University of Oxford.
Sensyne Health, a UK-based healthcare technology developer partially based on research at University of Oxford, raised £60m ($76m) in its initial public offering on Tuesday and will begin trading on Aim tomorrow.
The company issued approximately 34.3 million shares, priced at £1.75 each. It expects to have a market capitalisation of £225m when it commences trading.
Sensyne Health is developing clinically validated digital health products, such as prescribed digital therapeutics and hospital systems for clinical care, that rely on artificial…
